SKIN News & Events

Sees FY26 adjusted EBITDA $35M-$45M. The company said, "BeautyHealth enters 2026 with a strong foundation - a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus now is to unlock the full economic potential of our platform by strengthening commercial execution, expanding utilization, improving provider economics, and investing in clinically meaningful innovation."

Reports Q4 revenue $82.4M, consensus $78.12M. "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold," said Pedro Malha, President and CEO of BeautyHealth.

Sees Q1 adjusted EBITDA $3.5M-$5.5M.